抗免疫球蛋白E疗法成功治疗日光性荨麻疹。 - Suppr

Suppr

超能文献

Successful treatment of solar urticaria with anti-immunoglobulin E therapy.

作者信息

Güzelbey O, Ardelean E, Magerl M, Zuberbier T, Maurer M, Metz M

机构信息

Department of Dermatology and Allergy, Charité Universitätsmedizin Berlin, D - 10117 Berlin, Germany.

出版信息

Allergy. 2008 Nov;63(11):1563-5. doi: 10.1111/j.1398-9995.2008.01879.x.

DOI:10.1111/j.1398-9995.2008.01879.x

PMID:18925897

Abstract

摘要

相似文献

Successful treatment of solar urticaria with anti-immunoglobulin E therapy.

Allergy. 2008 Nov;63(11):1563-5. doi: 10.1111/j.1398-9995.2008.01879.x.

Antihistamine-resistant urticaria factitia successfully treated with anti-immunoglobulin E therapy.

Allergy. 2010 Nov;65(11):1494-5. doi: 10.1111/j.1398-9995.2010.02409.x.

Omalizumab also successful in chronic urticaria.

J Allergy Clin Immunol. 2008 Mar;121(3):784; author reply 784-5. doi: 10.1016/j.jaci.2007.12.1174.

Partial improvement of solar urticaria after omalizumab.

J Allergy Clin Immunol. 2010 Feb;125(2):490-1. doi: 10.1016/j.jaci.2009.11.007.

Successful treatment of cholinergic urticaria with anti-immunoglobulin E therapy.

Allergy. 2008 Feb;63(2):247-9. doi: 10.1111/j.1398-9995.2007.01591.x.

Anti-immunoglobulin E treatment of patients with recalcitrant physical urticaria.

Int Arch Allergy Immunol. 2011;154(2):177-80. doi: 10.1159/000320233. Epub 2010 Aug 24.

A critical appraisal of omalizumab as a therapeutic option for chronic refractory urticaria/angioedema.

Ann Allergy Asthma Immunol. 2014 Apr;112(4):276-9. doi: 10.1016/j.anai.2014.01.019. Epub 2014 Feb 28.

Ice cream urticaria.

Am J Med. 2010 Dec;123(12):e1-2. doi: 10.1016/j.amjmed.2010.04.034. Epub 2010 Oct 19.

Efficacy of omalizumab in delayed pressure urticaria: a case report.

Allergy. 2010 Jan;65(1):138-9. doi: 10.1111/j.1398-9995.2009.02188.x. Epub 2009 Oct 5.

Clinical efficacy of reserpine as "add-on therapy" to antihistamines in patients with recalcitrant chronic idiopathic urticaria and urticarial vasculitis.

J Dermatol. 2010 Sep;37(9):827-9. doi: 10.1111/j.1346-8138.2010.00881.x.

引用本文的文献

The many faces of pediatric urticaria.

Front Allergy. 2023 Nov 3;4:1267663. doi: 10.3389/falgy.2023.1267663. eCollection 2023.

Tracing Human IgE B Cell Antigen Receptor-Bearing Cells With a Monoclonal Anti-Human IgE Antibody That Specifically Recognizes Non-Receptor-Bound IgE.

Front Immunol. 2021 Dec 20;12:803236. doi: 10.3389/fimmu.2021.803236. eCollection 2021.

Clinical impact of omalizumab in refractory chronic urticaria: One centre experience.

Exp Ther Med. 2019 Dec;18(6):5078-5081. doi: 10.3892/etm.2019.8126. Epub 2019 Oct 24.

Tracing IgE-Producing Cells in Allergic Patients.

Cells. 2019 Aug 28;8(9):994. doi: 10.3390/cells8090994.

Solar Urticaria, a Disease with Many Dark Sides: Is Omalizumab the Right Therapeutic Response? Reflections from a Clinical Case Report.

Open Med (Wars). 2019 Jun 7;14:403-406. doi: 10.1515/med-2019-0042. eCollection 2019.

Consensus Statement for the Diagnosis and Treatment of Urticaria: A 2017 Update.

Indian J Dermatol. 2018 Jan-Feb;63(1):2-15. doi: 10.4103/ijd.IJD_308_17.

Omalizumab efficacy in cases of chronic spontaneous urticaria is not explained by the inhibition of sera activity in effector cells.

Sci Rep. 2017 Aug 21;7(1):8985. doi: 10.1038/s41598-017-09361-4.

Review of Physical Urticarias and Testing Methods.

Curr Allergy Asthma Rep. 2017 Aug;17(8):51. doi: 10.1007/s11882-017-0722-1.

J Immunol Res. 2016;2016:8163803. doi: 10.1155/2016/8163803. Epub 2016 Dec 21.

Chronic spontaneous urticaria: latest developments in aetiology, diagnosis and therapy.

Ther Adv Chronic Dis. 2015 Nov;6(6):304-13. doi: 10.1177/2040622315603951.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Successful treatment of solar urticaria with anti-immunoglobulin E therapy.

Allergy. 2008 Nov;63(11):1563-5. doi: 10.1111/j.1398-9995.2008.01879.x.

Antihistamine-resistant urticaria factitia successfully treated with anti-immunoglobulin E therapy.

Allergy. 2010 Nov;65(11):1494-5. doi: 10.1111/j.1398-9995.2010.02409.x.

Omalizumab also successful in chronic urticaria.

J Allergy Clin Immunol. 2008 Mar;121(3):784; author reply 784-5. doi: 10.1016/j.jaci.2007.12.1174.

Partial improvement of solar urticaria after omalizumab.

J Allergy Clin Immunol. 2010 Feb;125(2):490-1. doi: 10.1016/j.jaci.2009.11.007.

Successful treatment of cholinergic urticaria with anti-immunoglobulin E therapy.

Allergy. 2008 Feb;63(2):247-9. doi: 10.1111/j.1398-9995.2007.01591.x.

Anti-immunoglobulin E treatment of patients with recalcitrant physical urticaria.

Int Arch Allergy Immunol. 2011;154(2):177-80. doi: 10.1159/000320233. Epub 2010 Aug 24.

A critical appraisal of omalizumab as a therapeutic option for chronic refractory urticaria/angioedema.

Ann Allergy Asthma Immunol. 2014 Apr;112(4):276-9. doi: 10.1016/j.anai.2014.01.019. Epub 2014 Feb 28.

Ice cream urticaria.

Am J Med. 2010 Dec;123(12):e1-2. doi: 10.1016/j.amjmed.2010.04.034. Epub 2010 Oct 19.

Efficacy of omalizumab in delayed pressure urticaria: a case report.

Allergy. 2010 Jan;65(1):138-9. doi: 10.1111/j.1398-9995.2009.02188.x. Epub 2009 Oct 5.

Clinical efficacy of reserpine as "add-on therapy" to antihistamines in patients with recalcitrant chronic idiopathic urticaria and urticarial vasculitis.

J Dermatol. 2010 Sep;37(9):827-9. doi: 10.1111/j.1346-8138.2010.00881.x.

引用本文的文献

The many faces of pediatric urticaria.

Front Allergy. 2023 Nov 3;4:1267663. doi: 10.3389/falgy.2023.1267663. eCollection 2023.

Tracing Human IgE B Cell Antigen Receptor-Bearing Cells With a Monoclonal Anti-Human IgE Antibody That Specifically Recognizes Non-Receptor-Bound IgE.

Front Immunol. 2021 Dec 20;12:803236. doi: 10.3389/fimmu.2021.803236. eCollection 2021.

Clinical impact of omalizumab in refractory chronic urticaria: One centre experience.

Exp Ther Med. 2019 Dec;18(6):5078-5081. doi: 10.3892/etm.2019.8126. Epub 2019 Oct 24.

Tracing IgE-Producing Cells in Allergic Patients.

Cells. 2019 Aug 28;8(9):994. doi: 10.3390/cells8090994.

Solar Urticaria, a Disease with Many Dark Sides: Is Omalizumab the Right Therapeutic Response? Reflections from a Clinical Case Report.

Open Med (Wars). 2019 Jun 7;14:403-406. doi: 10.1515/med-2019-0042. eCollection 2019.

Consensus Statement for the Diagnosis and Treatment of Urticaria: A 2017 Update.

Indian J Dermatol. 2018 Jan-Feb;63(1):2-15. doi: 10.4103/ijd.IJD_308_17.

Omalizumab efficacy in cases of chronic spontaneous urticaria is not explained by the inhibition of sera activity in effector cells.

Sci Rep. 2017 Aug 21;7(1):8985. doi: 10.1038/s41598-017-09361-4.

Review of Physical Urticarias and Testing Methods.

Curr Allergy Asthma Rep. 2017 Aug;17(8):51. doi: 10.1007/s11882-017-0722-1.

J Immunol Res. 2016;2016:8163803. doi: 10.1155/2016/8163803. Epub 2016 Dec 21.

Chronic spontaneous urticaria: latest developments in aetiology, diagnosis and therapy.

Ther Adv Chronic Dis. 2015 Nov;6(6):304-13. doi: 10.1177/2040622315603951.